Text & Content Analysis

Context: entity (sermorelin)  |  Window: 24h Β· 7d Β· 30d  |  Corpus: 1 articles

This page analyzes how a selected category, entity, or narrative frame appears in recent news coverage within the specified time window. Metrics and breakdowns are derived from the active article corpus.

Corpus KPIs

Entity
sermorelin
Window
Last 24h
Articles
1
From
2026-08-24 11:30:00+00
To
2026-08-24 11:30:00+00
Range
2026-08-23 22:38:03.161926+00 β†’ 2026-08-24 22:38:03.161926+00
Who’s being talked about

Top Entities

Entity Label Mentions Actions
about vector science therapeutics corp ORG 1 πŸ“Š πŸ” 🧲
bill jackson PERSON 1 πŸ“Š πŸ” 🧲
bpc157 ORG 1 πŸ“Š πŸ” 🧲
canadian NORP 1 πŸ“Š πŸ” 🧲
company ORG 1 πŸ“Š πŸ” 🧲
epitalon PERSON 1 πŸ“Š πŸ” 🧲
fda ORG 1 πŸ“Š πŸ” 🧲
glp1s PRODUCT 1 πŸ“Š πŸ” 🧲
independent quality verification ORG 1 πŸ“Š πŸ” 🧲
iso ORG 1 πŸ“Š πŸ” 🧲
kpv ORG 1 πŸ“Š πŸ” 🧲
lyogenesis manufacturing ORG 1 πŸ“Š πŸ” 🧲
lyogenesis manufacturing comes online news ORG 1 πŸ“Š πŸ” 🧲
lyogenesis manufacturings ORG 1 πŸ“Š πŸ” 🧲
mequon PRODUCT 1 πŸ“Š πŸ” 🧲
milestone ORG 1 πŸ“Š πŸ” 🧲
nad ORG 1 πŸ“Š πŸ” 🧲
one CARDINAL 1 πŸ“Š πŸ” 🧲
process ORG 1 πŸ“Š πŸ” 🧲
regulation services provider ORG 1 πŸ“Š πŸ” 🧲
request a demo ORG 1 πŸ“Š πŸ” 🧲
science and therapeutics corp ORG 1 πŸ“Š πŸ” 🧲
semax GPE 1 πŸ“Š πŸ” 🧲
sermorelin ORG 1 πŸ“Š πŸ” 🧲
share to x 55000 PRODUCT 1 πŸ“Š πŸ” 🧲
Who’s talking

Top Sources (Domains)

Domain Articles % Actions
prnewswire.com 1 100.00 πŸ“Š πŸ“° 🧲
How the stories are being framed

Top Narrative Frames

Frame Weight Actions
Government 0.2800 πŸ“Š 🧲
Technology 0.2200 πŸ“Š 🧲
Health 0.1700 πŸ“Š 🧲
Environment, Climate 0.1600 πŸ“Š 🧲
Business, Companies 0.1000 πŸ“Š 🧲
Entertainment 0.0700 πŸ“Š 🧲
How it feels

Sentiment

Label Articles Actions
😐 Neutral 1 πŸ“Š 🧲

Articles included

Top entities
Top sources
Top narrative frames
Pub Date Category Domain Title Analyze Author Sent Score
2026-08-24 11:30:00+00 Science prnewswire.com Vector Science & Therapeutics (TSXV: PAIN) Begins Peptide Production as First Suite at LyoGenesis Manufacturing Comes Online Analyze Vector Sciences & Therapeutics 😐 neutral 0.0686